HIV molecular immunology database
PLTEEAELELAENREILKEPVHGVY
|
Pol(449-473) | A2 human epitope |
EAELELAENREILKE
|
Pol(453-467) | human epitope |
aAELELAENREILKE
|
Pol(453-467) | observed variant |
EAgfELAENREILKE
|
Pol(453-467) | observed variant |
EAgLELAENREILKE
|
Pol(453-467) | observed variant |
EAELELAENREILeE
|
Pol(453-467) | observed variant |
EAELELAgNREILKE
|
Pol(453-467) | observed variant |
ELAENREILKEPVHGVYY
|
Pol(457-474) | C*01, C*02 human epitope |
ELAENREILKEPVHGVYY
|
Pol(457-474) | C*02:02 human epitope |
ELAENREILKEPVHGVYY
|
Pol(457-474) | human epitope |
AENREILKE
|
Pol(459-467) | human epitope |
KNREILKDPVHGVYYD
|
Pol(460-475) | human epitope |
EILKEPVGHV
|
Pol(463-472) | A*02:01 human epitope |
EILKEPVHGV
|
Pol(463-472) | A*02:01 humanized mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILRIPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILqEPVHGV
|
Pol(464-472) | observed variant |
ILKEPVHGa
|
Pol(464-472) | observed variant |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human, transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 humanized mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGa
|
Pol(464-472) | inferred escape |
ILKEPiHGa
|
Pol(464-472) | inferred escape |
ILrEPVHGV
|
Pol(464-472) | inferred escape |
ILKEPVHea
|
Pol(464-472) | inferred escape |
ILKgPVHGa
|
Pol(464-472) | inferred escape |
ILeEPVHGa
|
Pol(464-472) | inferred escape |
ILrEPVHGa
|
Pol(464-472) | inferred escape |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 humanized mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKDPVHGV
|
Pol(464-472) | A*02:01 humanized mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 humanized mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human, macaque epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01, A*02:05 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:01, A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A*02:02, A2 human epitope |
ILKdPVHGV
|
Pol(464-472) | susceptible form |
ILKEPVHGV
|
Pol(464-472) | A2 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHeV
|
Pol(464-472) | susceptible form |
ILKdPVHGV
|
Pol(464-472) | non-susceptible form |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKdPVHGV
|
Pol(464-472) | diminished response |
ILKdPVHeV
|
Pol(464-472) | diminished response |
yLKEPVHGV
|
Pol(464-472) | susceptible form |
fLKEPVHGV
|
Pol(464-472) | susceptible form |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKdPVHGV
|
Pol(464-472) | observed variant |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKdPVHGV
|
Pol(464-472) | subtype-specific non-susceptible form |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKDPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human, transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKDPVHGV
|
Pol(464-472) | A2 human epitope |
ILKePVHGV
|
Pol(464-472) | susceptible form |
ILRIPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKDPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKElVHGV
|
Pol(464-472) | escape documented in this paper |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGa
|
Pol(464-472) | observed variant |
IiKEPVHxx
|
Pol(464-472) | observed variant |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human, transgenic mouse epitope |
ILKdPVHGV
|
Pol(464-472) | diminished response |
ILKEPVHrV
|
Pol(464-472) | susceptible form |
ILrEPiHGV
|
Pol(464-472) | susceptible form |
ILKEPVHGi
|
Pol(464-472) | susceptible form |
ILKEPVHGV
|
Pol(464-472) | A2 transgenic mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 human epitope |
ILKEPVHGV
|
Pol(464-472) | A2 supertype human, mouse epitope |
ILKEPVHGV
|
Pol(464-472) | A2 supertype human epitope |
ILKEPVHGV
|
Pol(464-472) | human epitope |
ILKEPVHGV
|
Pol(464-472) | human epitope |
ILKEPVHGV
|
Pol(464-472) | human epitope |
ILKEPVHGV
|
Pol(464-472) | human epitope |
ILKEPVHGV
|
Pol(464-472) | human epitope |
IKLEPVHGVY
|
Pol(464-473) | A*02 human epitope |
ILKEPVHGVY
|
Pol(464-473) | A*02 human epitope |
ILKEPVHGVY
|
Pol(464-473) | A2 human epitope |
ILKEPVHGVY
|
Pol(464-473) | A2 human epitope |
IKLEPVHGVY
|
Pol(464-473) | A*68:02 human epitope |
IKLEPVHGVY
|
Pol(464-473) | B*15 human epitope |
ILKEPVHGVY
|
Pol(464-473) | B*15 human epitope |
IKLEPVHGVY
|
Pol(464-473) | B*15 human epitope |
IKLEPVHGVY
|
Pol(464-473) | B*15 human epitope |
ILKEPVHGVY
|
Pol(464-473) | B15 human epitope |
ILKEPVHGVY
|
Pol(464-473) | B15 human epitope |
ILKEPVHGVY
|
Pol(464-473) | B*15:01 human epitope |
IKLEPVHGVY
|
Pol(464-473) | B*15:01 human epitope |
IKLEPVHGVY
|
Pol(464-473) | B*15:03 human epitope |
ILKEPVHGVY
|
Pol(464-473) | B*15:10 human epitope |
ILKEPVHGaY
|
Pol(464-473) | diminished response; escape documented in this paper; non-susceptible form |
ILKEtVHGaY
|
Pol(464-473) | diminished response; escape documented in this paper; non-susceptible form |
ILKEsVHGaY
|
Pol(464-473) | diminished response; escape documented in this paper; non-susceptible form |
ILKaPVHGaY
|
Pol(464-473) | diminished response; escape documented in this paper; non-susceptible form |
ILKkPVHGaY
|
Pol(464-473) | diminished response; escape documented in this paper; non-susceptible form |
ILrEPVHGaY
|
Pol(464-473) | diminished response; escape documented in this paper; non-susceptible form |
ILrEPVHGVY
|
Pol(464-473) | diminished response; escape documented in this paper; non-susceptible form |
IKLEPVHGVY
|
Pol(464-473) | B*62 human epitope |
ILKEPVHGVY
|
Pol(464-473) | B62 human epitope |
ILKEPVHGVY
|
Pol(464-473) | B62 human epitope |
IKLEPVHGVY
|
Pol(464-473) | B*81 human epitope |
ILKEPVHGVY
|
Pol(464-473) | C*03:03 human epitope |
ILrEPVHGVY
|
Pol(464-473) | escape documented in this paper |
IKLEPVHGVY
|
Pol(464-473) | C*12 human epitope |
ILKEPVHGVY
|
Pol(464-473) | C*12:02 human epitope |
ILKEPVHGaY
|
Pol(464-473) | escape documented in this paper; reversion |
ILKEPVHGVY
|
Pol(464-473) | C*12:02 human epitope |
ILKEPVHGaY
|
Pol(464-473) | altered KIR binding or increased/decreased off-rate |
ILKEPVHGVY
|
Pol(464-473) | C*12:02 human epitope |
ILKEPVHGVY
|
Pol(464-473) | human epitope |
ILKEPVHGVYY
|
Pol(464-474) | B*52:01 human epitope |
ILrEPVHGVYY
|
Pol(464-474) | diminished HLA binding or increased off-rate; observed variant |
ILKEPVHGVYY
|
Pol(464-474) | C*12:02 human epitope |
ILKEPVHGVYY
|
Pol(464-474) | C*12:02 human epitope |
LKEPVHGV
|
Pol(465-472) | human epitope |
LKEPVHGVY
|
Pol(465-473) | human epitope |
LKDPVHGVYYDPSKD
|
Pol(465-479) | human epitope |
LKDPVHGVYYDPSKD
|
Pol(465-479) | human epitope |
KEPVHGVYY
|
Pol(466-474) | human epitope |
VHGVYYDPSKDLIAE
|
Pol(469-483) | mouse epitope |
VYYDPSKDL
|
Pol(472-480) | A24 human epitope |
VYYDPSKDL
|
Pol(472-480) | A*36 human epitope |
VYYDPSKDLI
|
Pol(472-481) | H-2Kd mouse epitope |
VYYDPSKDLv
|
Pol(472-481) | susceptible form |
VYYDPtKDLI
|
Pol(472-481) | susceptible form |
VYYDPSKeLI
|
Pol(472-481) | diminished response; non-susceptible form |
aYYDPSKeLI
|
Pol(472-481) | diminished response; non-susceptible form |
VYYePSKeLI
|
Pol(472-481) | diminished response; non-susceptible form |
VYYDPSKDIA
|
Pol(472-481) | H-2Kd mouse epitope |
VYYDPSKDLI
|
Pol(472-481) | H-2d human, mouse epitope |
VYYDPSKDLIA
|
Pol(472-482) | H-2Kd mouse epitope |